May 27, 2026 08:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026
Feb 23, 2026 08:00AM
Nov 19, 2025 08:00AM
Sep 26, 2025 08:00AM
Aug 13, 2025 04:05PM
Aug 13, 2025 04:05PM
Aug 11, 2025 04:05PM
Aug 11, 2025 04:05PM BioVie Inc. Announces Closing of $12 Million Public Offering
Aug 7, 2025 08:43PM
Aug 7, 2025 08:43PM
Jul 24, 2025 08:01AM
Jul 24, 2025 08:00AM
Jul 22, 2025 09:05AM
Jul 22, 2025 08:00AM
Jul 9, 2025 08:00AM BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference
Jun 26, 2025 08:00AM
Jun 24, 2025 04:05PM
May 15, 2025 08:00AM
May 14, 2025 07:30AM
May 7, 2025 08:00AM
May 5, 2025 08:02AM
May 5, 2025 08:00AM BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth
Apr 16, 2025 08:00AM
Mar 27, 2025 08:00AM
Nov 20, 2024 08:00AM
Nov 4, 2024 08:00AM
Oct 29, 2024 04:05PM
Oct 28, 2024 04:10PM
Oct 28, 2024 04:10PM UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Oct 28, 2024 03:15PM
Oct 28, 2024 03:13PM
Oct 24, 2024 04:10PM
Oct 23, 2024 03:25PM
Oct 23, 2024 03:24PM
Oct 23, 2024 08:00AM
Oct 22, 2024 04:01PM BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
Oct 21, 2024 03:08PM
Oct 21, 2024 03:08PM
Oct 15, 2024 08:06AM
Oct 15, 2024 08:00AM
Oct 1, 2024 08:05AM
Oct 1, 2024 08:00AM
Sep 25, 2024 04:05PM BioVie Inc. Announces Closing of Public Offering
Sep 24, 2024 06:22AM

445,459 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All